no more compounded semaglutide π’ FDA has determined the shortage of injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the The FDA's Decision to Ban
Description
IT'S A LIFESTYLE
Shaking introduces mechanical energy that can denature the peptide, breaking the bonds that maintain its biological activity
In support of this idea, ablation of GLP1 receptors in the adult (using AAVCre injected directly into the paraventricular hypothalamic nucleus) resulted in marked obesity whereas constitutive deletion of GLP1 receptors in the paraventricular hypothalamic nucleus (using Sim1Cre) failed to alter energy balance (Table 2) (Burmeister et al., 2017
Meal timing and portion control How you eat matters as much as what you eat when it comes to sulfur burps on GLP-1 medications
